Search

Design Therapeutics Inc

Закрыт

12.37 2.23

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

11.73

Макс.

12.46

Ключевые показатели

By Trading Economics

Доход

-2.5M

-20M

Прибыль на акцию

-0.32

Сотрудники

55

EBITDA

-4.5M

-22M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+127.01% upside

Дивиденды

By Acuity

Следующий отчет о доходах

3 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

43M

785M

Предыдущая цена открытия

10.14

Предыдущая цена закрытия

12.37

Design Therapeutics Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

28 сент. 2026 г., 23:56 UTC

Scotts Miracle-Gro Co is down in after-market hours, marking a fifth consecutive session of lower performance and remaining below its 20-day moving average.

28 сент. 2026 г., 23:56 UTC

Correlated Moves

BILL Holdings Inc trades modestly higher in after-market hours, supported by positive momentum in Gen Digital Inc following optimistic comments on its fiscal 2027 outlook.

28 сент. 2026 г., 23:56 UTC

Correlated Moves

Pinnacle West Capital Corp traded modestly higher in after-market hours, maintaining a steady return since Monday's close, despite broader market conditions.

28 сент. 2026 г., 23:56 UTC

Patterson-UTI Energy Inc is gaining modestly in after-market trading, continuing a routine move since Monday's close while remaining below its 20-day moving average.

28 сент. 2026 г., 23:55 UTC

Gray Media Inc has advanced modestly in after-market trading, reflecting a shift in momentum despite remaining below its 20-day moving average.

28 сент. 2026 г., 23:55 UTC

Voya Financial Inc is trading lower in after-market hours, remaining near the low end of its one-month range and below its 20-day moving average.

28 сент. 2026 г., 23:55 UTC

Global Net Lease Inc is trading modestly higher in after-market hours, reflecting stronger performance compared to the previous seven sessions that all ended lower.

28 сент. 2026 г., 23:55 UTC

News

Neurocrine Biosciences shares rise in after-market trading following the return of Eiry W. Roberts, M.D., as Chief Medical Officer, ensuring continuity for late-stage programs.

28 сент. 2026 г., 23:55 UTC

Emerson Electric Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and showing notable upward movement since Monday's close.

28 сент. 2026 г., 23:55 UTC

Huntington Bancshares Inc is trading modestly higher in after-market hours, stabilizing above earlier session lows while remaining below its 20-day moving average.

28 сент. 2026 г., 23:55 UTC

F5 Inc's shares are trading modestly lower in after-market hours, continuing a downward trend that has persisted for five consecutive sessions.

28 сент. 2026 г., 23:55 UTC

Xenon Pharmaceuticals Inc. is trading lower in after-hours, shifting from a slight gain to a more substantial loss since Monday's close, remaining below its 20-day moving average.

28 сент. 2026 г., 23:55 UTC

CMS Energy Corp is trading modestly higher in after-market hours, recovering from a low point immediately after the regular session close.

28 сент. 2026 г., 23:55 UTC

APA Corp's shares advanced modestly in after-market trading, stabilizing after earlier gains but remaining below the 20-day moving average.

28 сент. 2026 г., 23:51 UTC

Novavax Inc. traded modestly higher during after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

28 сент. 2026 г., 23:51 UTC

Leonardo DRS Inc is trading modestly higher in after-market hours, rebounding from an earlier session low and showing unusual strength compared to typical patterns.

28 сент. 2026 г., 23:51 UTC

News

ACADIA Pharmaceuticals shares declined in after-market hours despite the allowance of a U.S. patent for weight-banded dosing of trofinetide, extending protections until March 2041.

28 сент. 2026 г., 23:51 UTC

In after-market trading, MercadoLibre Inc is rising following four sessions of decline, amid significant gains in the Broadline Retail sub-sector.

28 сент. 2026 г., 23:51 UTC

Peloton Interactive Inc is declining in after-market trading, hitting its lowest point of the day and remaining below its 20-day moving average.

28 сент. 2026 г., 23:51 UTC

EHang Holdings Ltd is rising in after-market trading, gaining ground after five consecutive lower sessions, despite remaining below its 20-day moving average.

28 сент. 2026 г., 23:51 UTC

CF Industries Holdings Inc saw a modest decline in after-market trading, remaining near the lower end of its one-month range and below its 20-day moving average.

28 сент. 2026 г., 23:51 UTC

Affiliated Managers Group Inc is trading lower in after-market hours, continuing a decline since Monday's close despite earlier gains during the session.

28 сент. 2026 г., 23:51 UTC

Qfin Holdings Inc saw a notable rise in after-market trading, advancing sharply following eight consecutive lower daily finishes, though still below its 20-day moving average.

28 сент. 2026 г., 23:51 UTC

News

Prospect Capital Corp shares are trading higher in after-market hours following a cash distribution announcement of $0.56232 per share from its fund.

28 сент. 2026 г., 23:51 UTC

Block Inc declined in after-market hours, continuing a trend of lower closes amid broader market weakness and trading significantly below its 20-day moving average.

28 сент. 2026 г., 23:51 UTC

Australia's Balance of Trade report on October 1 is expected to show a AUD 2.1 billion surplus, reflecting strong resource exports amid cautious market optimism and global inflation concerns.

28 сент. 2026 г., 23:51 UTC

JOLTs Job Openings Data Release on September 29 Expected to Show Decline Amid Rising Inflation Fears and Geopolitical Tensions, Influencing Fed Rate Hike Speculations.

28 сент. 2026 г., 23:51 UTC

US Initial Jobless Claims Expected at 200K, Indicating Labor Market Resilience Amid Inflation Concerns

28 сент. 2026 г., 23:51 UTC

News

Boston Scientific Corp. has secured a contract worth up to $135.7 million from the U.S. Department of Defense, while shares have moved modestly lower in after-market trading.

28 сент. 2026 г., 23:51 UTC

Molson Coors Beverage Co's shares traded modestly higher in after-market hours on Monday, despite fluctuations and positioning below the 20-day moving average.

Сравнение c конкурентами

Изменение цены

Design Therapeutics Inc Прогноз

Целевая цена

By TipRanks

127.01% рост

Прогноз на 12 месяцев

Средняя 27.513 USD  127.01%

Максимум 40.54 USD

Минимум 20 USD

Основано на мнении 3 аналитиков Wall Street, спрогнозировавших целевые цены для Design Therapeutics Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

3 ratings

3

Покупка

0

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.